Can America Win The AI Biotech Race Against China? | Lada Nuzhna & Elliot Hershberg
Episode
62 min
Read time
2 min
Topics
Artificial Intelligence, Science & Discovery
AI-Generated Summary
What It Covers
Lada Nuzhna and Elliot Hershberg analyze American biotech's competitive disadvantage against China, exploring regulatory barriers, AI's potential impact, and aging research opportunities.
Notable Moment
Nuzhna reveals that George Yancopoulos paid ten thousand dollars per patient in Regeneron trials, while current costs have ballooned to five hundred thousand dollars per patient.
You just read a 3-minute summary of a 59-minute episode.
Get a16z Podcast summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from a16z Podcast
We summarize every new episode. Want them in your inbox?
Samo Burja on Growth, Energy, and AI
Designing the Physical World with AI
Tyler Cowen & Alex Tabarrok on AI, Jobs, and Economic Growth
Building Search for AI Agents with Exa CEO Will Bryk
AI Agents and the Fight for Customer Data
Similar Episodes
Related episodes from other podcasts
We Study Billionaires
Feb 13
TIP791: Best Quality Stock Idea Q1 2026 w/ Clay Finck
Biotech Hangout
Nov 21
Episode 164 - November 21, 2025
The Prof G Pod
Jun 11
The New Rules of Power — with Anne Applebaum and Fiona Hill
We Study Billionaires
Jun 11
TIP822: QXO (QXO): Can One of the World's Best Consolidators Strike Lightning Again? w/ Kyle Grieve & Shawn O'Malley
The Knowledge Project
Jun 9
Mental Models That Change How You Think | Bill Gurley
Explore Related Topics
This podcast is featured in Best Business Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's AI & Machine Learning Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into a16z Podcast.
Every Monday, we deliver AI summaries of the latest episodes from a16z Podcast and 192+ other podcasts. Free for up to 3 shows.
Start My Monday DigestNo credit card · Unsubscribe anytime